OMX Ventures was founded upon the simple idea that in this new Century of Biology, scientists and engineers will radically remake the future of medicine through the use of better tools, big data and computing, and the forward application of biologic insights for the creation of new tools and technologies. Contact us: info@omx.vc
Employees: 1-10
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 21
Date | Name | Website | Total Raised | Location |
06.11.2023 | VedaBio | vedabio.com | $40M | - |
06.11.2023 | Constructi... | constructive.bio | $15M | United Kin... |
25.07.2022 | Replay Hol... | replay.bio | $56.5M | United Sta... |
28.09.2021 | Delix Ther... | delixtherapeutics.com | $100M | United Sta... |
- | General In... | generalinception.com | - | United Sta... |
- | Lightcast ... | lightcastd.com | - | United Kin... |
- | 1859 | eighteenfiftynine.com | $40M | United Sta... |
- | SyntheX | synthexlabs.com | - | United Sta... |
- | Mythic | mythictx.com | $103M | United Sta... |
- | Sestina Bi... | sestinabio.com | - | United Sta... |
Show more
Persons 3
Date | First Name | Last Name | Title | Location | |||
- | Natasha | Azar | - | linkedin.c... | - | - | - |
- | Paul | Conley | - | linkedin.c... | - | - | - |
- | Swetha | Murali | - | linkedin.c... | - | - | - |
Mentions in press and media 4
Date | Title | Description |
06.05.2024 | OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors | What You Should Know: – OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing VC, the round saw participa... |
15.08.2022 | Re-engineering biology, Constructive Bio scores $15 million to make new class of enzymes | Cambridge-based biotech startup Constructive Bio has raised $15 million in funding to create technology for producing synthetic genomes and reprogramming the genetic code of living organisms. This, in turn, will allow scientists to write en... |
25.07.2022 | Decibio Ventures Invests In Replay’s $55 Million Seed Funding Round Led By KKR & Co. And OMX Ventures | DeciBio Ventures, a venture capital firm investing in and advising precision medicine start-ups, invested in the seed funding round for Replay. KKR & Co. Inc. and OMX Ventures led this funding round, which totaled $55 million. Additiona... |
28.07.2021 | OMX Ventures Adds Swetha Murali As A Senior Associate | OMX Ventures, a life sciences venture capital firm investing in companies that operate at the intersection of biology, big data, and engineering, announced that Swetha Murali, Ph.D. has joined the OMX team as a Senior Associate based in Bos... |